Skip to main content

Cookies on UKHSA data dashboard

We use some essential cookies to make this service work.

We'd like to set additional cookies so we can remember your settings, understand how people use the service and make improvements.

View cookies
UKHSA data dashboard

BetaThis is a new service - your feedback will help us to improve it.

Information
Changes to when we publish influenza and RSV data

We are changing how often we publish our influenza and RSV data. From 29 May, we will update metrics for both influenza and RSV every 2 weeks instead of weekly. We will resume weekly updates in October this year.

Entry title:

Antimicrobial resistance in Enterococcus faecalis (E. faecalis)

Last updated on Thursday, 29 May 2025 at 04:00pm

This page provides information on resistance to antimicrobials in Enterococcus faecalis bacteraemia (bacteria found in blood specimens). Data breakdowns are available for England and by UKHSA Region.

Filter results by location
Reset

Glycopeptides

Testing

Rolling monthly average number of E. faecalis bacteraemia tested for resistance to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Feb 2025

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for E-faecalis. Specifically the metric 'e-faecalis_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2020 to 01 February 2025. It rose from 250.67 on 01 April 2020 to 282.67 on 01 January 2021. It rose from 291.0 on 01 February 2021 to 311.0 on 01 November 2021. It rose from 301.33 on 01 December 2021 to 302.33 on 01 September 2022. It fell from 305.0 on 01 October 2022 to 301.33 on 01 July 2023. It rose from 313.33 on 01 August 2023 to 321.0 on 01 May 2024. And finally. It rose from 322.0 on 01 June 2024 to 335.33 on 01 February 2025. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of E. faecalis bacteraemia tested for resistance to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 February 2025

MonthNumber tested
1 Feb 2025335.33
1 Jan 2025350.33
1 Dec 2024335.67
1 Nov 2024335.67
1 Oct 2024328.67
1 Sep 2024325.33
1 Aug 2024327.67
1 Jul 2024327
1 Jun 2024322
1 May 2024321
1 Apr 2024317
1 Mar 2024316.33
1 Feb 2024315.33
1 Jan 2024313.67
1 Dec 2023317
1 Nov 2023312
1 Oct 2023327.33
1 Sep 2023317.33
1 Aug 2023313.33
1 Jul 2023301.33
1 Jun 2023309.33
1 May 2023328.33
1 Apr 2023324.67
1 Mar 2023314
1 Feb 2023296.33
1 Jan 2023303
1 Dec 2022307.33
1 Nov 2022311
1 Oct 2022305
1 Sep 2022302.33
1 Aug 2022290.33
1 Jul 2022284.33
1 Jun 2022287.67
1 May 2022296.33
1 Apr 2022286
1 Mar 2022279
1 Feb 2022271
1 Jan 2022290.67
1 Dec 2021301.33
1 Nov 2021311
1 Oct 2021320.33
1 Sep 2021316.67
1 Aug 2021304.67
1 Jul 2021290.33
1 Jun 2021281.33
1 May 2021292
1 Apr 2021286.67
1 Mar 2021299
1 Feb 2021291
1 Jan 2021282.67
1 Dec 2020259.67
1 Nov 2020250
1 Oct 2020254
1 Sep 2020252.33
1 Aug 2020253
1 Jul 2020249.33
1 Jun 2020253.67
1 May 2020250
1 Apr 2020250.67
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of E. faecalis bacteraemia tested for resistance to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Feb 2025

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for E-faecalis. Specifically the metric 'e-faecalis_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2020 to 01 February 2025. It fell from 97.28 on 01 April 2020 to 96.91 on 01 January 2021. It fell from 97.0 on 01 February 2021 to 96.58 on 01 November 2021. It fell from 96.78 on 01 December 2021 to 96.49 on 01 September 2022. It fell from 96.83 on 01 October 2022 to 96.78 on 01 July 2023. It fell from 98.12 on 01 August 2023 to 97.57 on 01 May 2024. And finally. It fell from 97.28 on 01 June 2024 to 97.1 on 01 February 2025. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of E. faecalis bacteraemia tested for resistance to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 February 2025

Month% tested
1 Feb 202597.1
1 Jan 202597.49
1 Dec 202497.38
1 Nov 202497.38
1 Oct 202497.04
1 Sep 202496.73
1 Aug 202496.46
1 Jul 202497.03
1 Jun 202497.28
1 May 202497.57
1 Apr 202497.54
1 Mar 202497.23
1 Feb 202496.92
1 Jan 202497.2
1 Dec 202397.84
1 Nov 202397.81
1 Oct 202398.2
1 Sep 202398.14
1 Aug 202398.12
1 Jul 202396.78
1 Jun 202397.17
1 May 202397.62
1 Apr 202398.48
1 Mar 202398.43
1 Feb 202397.69
1 Jan 202397.43
1 Dec 202297.46
1 Nov 202297.19
1 Oct 202296.83
1 Sep 202296.49
1 Aug 202297.32
1 Jul 202297.93
1 Jun 202297.95
1 May 202298.01
1 Apr 202297.95
1 Mar 202298.24
1 Feb 202297.83
1 Jan 202297.64
1 Dec 202196.78
1 Nov 202196.58
1 Oct 202196.1
1 Sep 202197.23
1 Aug 202197.44
1 Jul 202197.97
1 Jun 202197.57
1 May 202198.32
1 Apr 202197.61
1 Mar 202197.39
1 Feb 202197
1 Jan 202196.91
1 Dec 202097
1 Nov 202097.28
1 Oct 202097.69
1 Sep 202096.92
1 Aug 202096.93
1 Jul 202097.65
1 Jun 202097.68
1 May 202098.04
1 Apr 202097.28
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of E. faecalis bacteraemia resistant to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Feb 2025

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for E-faecalis. Specifically the metric 'e-faecalis_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2020 to 01 February 2025. It fell from 3.32 on 01 April 2020 to 2.36 on 01 January 2021. It rose from 3.21 on 01 February 2021 to 4.29 on 01 November 2021. It fell from 4.76 on 01 December 2021 to 3.75 on 01 September 2022. It fell from 3.39 on 01 October 2022 to 2.77 on 01 July 2023. It rose from 2.66 on 01 August 2023 to 3.22 on 01 May 2024. And finally. It fell from 3.0 on 01 June 2024 to 2.88 on 01 February 2025. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of E. faecalis bacteraemia resistant to glycopeptides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 February 2025

Month% resistant
1 Feb 20252.88
1 Jan 20252.66
1 Dec 20242.18
1 Nov 20242.98
1 Oct 20242.74
1 Sep 20244.1
1 Aug 20243.26
1 Jul 20243.77
1 Jun 20243
1 May 20243.22
1 Apr 20243.36
1 Mar 20243.16
1 Feb 20244.12
1 Jan 20244.04
1 Dec 20233.47
1 Nov 20232.67
1 Oct 20232.24
1 Sep 20233.26
1 Aug 20232.66
1 Jul 20232.77
1 Jun 20232.26
1 May 20232.94
1 Apr 20233.29
1 Mar 20233.18
1 Feb 20232.92
1 Jan 20233.19
1 Dec 20223.04
1 Nov 20223.54
1 Oct 20223.39
1 Sep 20223.75
1 Aug 20223.33
1 Jul 20223.52
1 Jun 20223.24
1 May 20223.94
1 Apr 20223.38
1 Mar 20223.35
1 Feb 20222.95
1 Jan 20224.01
1 Dec 20214.76
1 Nov 20214.29
1 Oct 20213.95
1 Sep 20213.37
1 Aug 20213.61
1 Jul 20212.76
1 Jun 20213.2
1 May 20212.63
1 Apr 20213.14
1 Mar 20213.01
1 Feb 20213.21
1 Jan 20212.36
1 Dec 20202.7
1 Nov 20203.2
1 Oct 20203.94
1 Sep 20203.57
1 Aug 20203.29
1 Jul 20203.07
1 Jun 20203.42
1 May 20203.2
1 Apr 20203.32
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Related content

Learn more about UKHSA data dashboard topics

Back to top